BeyondSpring Inc. (BYSI) Financials

BYSI Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 18.4 million 48.8 million
Dec. 31, 2025 25.9 million 49.9 million
Sept. 30, 2025 29.5 million 49.3 million
June 30, 2025 31.0 million 48.6 million

BYSI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -3.3 million 461000
Dec. 31, 2025 -5.7 million -77000
Sept. 30, 2025 -4.3 million 410000
June 30, 2025 -5.9 million 145000

BYSI Net Income

No data available :(

BYSI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 7.9 million - -
Dec. 31, 2025 12.6 million - 320000
Sept. 30, 2025 12.6 million - 93000
June 30, 2025 9.5 million - 477000

BYSI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 41.1 million
Dec. 31, 2025 40.4 million
Sept. 30, 2025 40.3 million
June 30, 2025 40.3 million

BYSI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 1.1 million 1.2 million -
Dec. 31, 2025 249 1.5 million 1.1 million -
Sept. 30, 2025 294 1.0 million 751000 -
June 30, 2025 146 1.0 million 947000 -

BYSI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 19000
Dec. 31, 2025 - 22000
Sept. 30, 2025 - 21000
June 30, 2025 - -

BYSI

Price: $1.61

52 week price:
1.18
3.44

Earnings Per Share: -0.20 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 157900

Ebitda: -18.6 million

Market Capitalization: 70.3 million

Links: